Long-term treatment of type 1 diabetes in the outpatient setting: Results of 934 patients during up to 10 years' follow-up

Canadian Journal of Diabetes

Volumn 28, Issue 3, 2004, Pages 190-195

  Tildesley, Hugh D ^a   Johns, Kevin W ^a  

^a NONE

Author keywords

A1C; Diabetes education program; Glycemic control; Hypoglycemic episodes; Insulin injections; Self monitoring of blood glucose

Indexed keywords

INSULIN;

BLOOD GLUCOSE MONITORING; FOLLOW UP; GENERAL CONDITION IMPROVEMENT; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; PATIENT EDUCATION; REVIEW;

EID: 28844465368     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
2. Worth R, Home PD, Johnston DG, et al. Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: Results of a controlled trial. Br Med J (Clin Res Ed). 1982;285:1233-1240.
3. Korhonen T, Huttunen JK, Aro A, et al. A controlled trial on the effects of patient education in the treatment of insulin-dependent diabetes. Diabetes Care. 1983;6:256-261.
4. Graber AL, Davidson P, Brown AW, et al. Dropout and relapse during diabetes care. Diabetes Care. 1992;15:1477-1483.
5. Pirart J. Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care. 1978;1:168-188, 252-263.
6. Klein R, Klein BEK, Moss SE, et al. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA. 1988;260:2864-2871.
7. Solders G, Tyden G, Persson A, et al. Improvement of nerve conduction in diabetic neuropathy. A follow-up study 4 yr after combined pancreatic and renal transplantation. Diabetes. 1992;41:946-951.
8. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet. 1986;328:1300-1304.
9. Orchard TJ, Dorman JS, Maser RE, et al. Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care. 1990;13:741-747.
10. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
11. Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group. Epidemiology of Diabetes Interventions and Complications (EDIC): Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999;22:99-111.
12. The DCCT Research Group. Weight gain associated with intensive therapy in the Diabetes Control and Complications Trial. Diabetes Care. 1988;11:567-573.
13. Bergada I, Suissa S, Dufresne J, et al. Severe hypoglycemia in IDDM children. Diabetes Care. 1989;12:239-244.
14. Tildesley HD, Haley LP, Vlahos WD, et al. Long-term experience in out-patient treatment of type 1 diabetes: Results of 396 patients after up to six years. Can J Diabetes Care. 1995;19:16-19.
15. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA. 1996;276:1409-1415.
16. Gilmer TP, O'Connor PJ, Manning WG, et al. The cost to health plans of poor glycemic control. Diabetes Care. 1997;20:1847-1853.